Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940

Immunology Letters

Volumn 91, Issue 1, 2004, Pages 11-16

  Gongora, Celine ^a   Hose, Stacey ^b   O'Brien, Terrence P ^b   Sinha, Debasish ^b,c  

^a CNRS   (France)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

CB1 cannabinoid receptor; CIITA class II MHC; CP55,940

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR AGONIST; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE CONTROL; GENETIC TRANSCRIPTION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0742306865     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2003.09.006     Document Type: Article

References (40)

1. Howlett AC, Bonner TI, Cabral GA, Casellas P, Devane WA, Felder CC, et al. In: Godfrain T, Humphrey P, Ruffolo R, Vanhoutte P, editors. IUPHAR Media; 1998. p. 97-104.
2. Zimmerman S., Zimmerman A.M., Cameron I.L., Laurence H.L. Pharmacology. 15:1977;10-23.
3. Miller J.F.A.P., Basten A., Sprent J., Cheers C. Cell Immunol. 2:1971;469-495.
4. Cushman P, Khurana R, Hashin G. In: Braude S, editor. Pharmacology of marihuana. New York: Raven Press; 1976. p. 207-10.
5. Cabral G.A., Mishkin E. J. Toxicol. Environ. Health. 26:1989;175-182.
6. Mann P.E.G., Cohen A.B., Finley T.N., Ladman A.L. Lab. Invest. 25:1971;111-120.
7. Klein T.W., Kawakami Y., Newton C., Friedman H. J. Toxicol. Environ. Health. 32:1991;465-477.
8. Lee M., Yang K.H., Kaminski N.E. J. Pharmacol. Exp. Ther. 275:1995;529-536.
9. Kaminski N.E., Abood M.E., Kessler F.K., Martin B.R., Schatz A.R. Mol. Pharmacol. 42:1992;736-742.
10. Smith S.H., Harris L.S., Uwaydah I.M., Munson A.E. J. Pharmacol. Exp. Ther. 207:1978;165-170.
11. Baczynsky W.O.T., Zimmerman A.M. Pharmacology. 26:1983;12-19.
12. Klein TW, Friedman H. In: Watson R, editor. Drugs of abuse and immune function. Boca Raton: CRC Press; 1990. p. 87-111.
13. Klein T.W., Newton C., Widen R., Friedman H. J. Immunopharmacol. 7:1985;451-466.
14. Specter S.C., Klein T.W., Newton C., Mondragon M., Widen R., Friedman H. Int. J. Immunopharmacol. 8:1986;741-745.
15. Kawakami Y., Klein T.W., Newton C., Djeu J.Y., Specter S., Friedman H. Int. J. Immunopharmacol. 10:1988a;485-488.
16. Balanchard D.K., Newton C., Klein T.W., Stewart W.E., Friedman H. Int. J. Immunopharmacol. 8:1986;819-824.
17. Zheng Z.M., Specter S.C. Int. J. Immunopharmacol. 14:1996;1445-1452.
18. Klein T.W., Newton C., Widen R., Friedman H. J. Pharmacol. Exp. Ther. 267:1993;635-640.
19. Klein T.W., Newton C.A., Nakachi N., Friedman H. J. Immunol. 164:2000;6461-6466.
20. Shivers S.C., Newton C., Friedman H., Klein T.W. Life Sci. 54:1994;1281-1289.
21. McCoy K.L., Gainey D., Cabral G.A. J. Phamacol. Exp. Ther. 273:1995;1216-1223.
22. McCoy K.L., Matveyeva M., Carlisle S.J., Cabral G. J. Pharmacol. Exp. Ther. 289:1999;1620-1625.
23. Jbilo O., Derocq J.M., Segui M., Le Fur G., Casellas P. FEBS Lett. 488:1999;273-277.
24. Derocq J.M., Jbilo O., Bouaboula M., Segui M., Clere C., Casellas P. J. Biol. Chem. 275:2000;15621-15628.
25. Carayon P., Marchand J., Dussossoy D., Derocq J.-M., Jbilo O., Bord A.et al. Blood. 92:1998;3605-3615.
26. Massi P., Fuzio D., Vigano D., Sacerdote P., Parolaro D. Eur. J. Pharmacol. 387:2000;343-347.
27. Sacerdote P., Massi P., Panerai A.E., Parolaro D. J. Neuroimmunol. 109:2000;155-163.
28. Gross A., Terraza A., Marchant J., Bouaboula M., Ouahrani-Bettache S., Liautard J-P.et al. J. Leukoc Biol. 67:2000;335-344.
29. Wakesman Y., Olson J.M., Carlisle S.J., Cabral G.A. J. Pharmacol. Exp. Ther. 288:1999;1357-1366.
30. Facchinetti F., del Guidice E., Furegato S., Passarotto M., Leon A. Glia. 41:2003;161-168.
31. Sinha D., Bonner T.I., Bhat N.R., Matsuda L.A. J. Neuroimmunol. 82:1998;13-21.
32. Tsujimura H., Tamura T., Gongora C., Aliberti J., Reis e Sousa C., Sher A.et al. Blood. 101:2003;961-969.
33. Kuwata T., Gongora C., Kanno Y., Sakaguchi K., Tamora T., Kanno T.et al. Mol. Cell. Biol. 22:2002;7439-7448.
34. Glimcher L.H., Kara C.J. Annu. Rev. Immunol. 10:1992;13-49.
35. Otten L.A., Steimle V., Bontron S., Mach B. Eur. J. Immunol. 28:1998;473-478.
36. Steimlev V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Science. 265:1994;106-109.
37. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. EMBO J. 16:1997;2851-2860.
38. Guzman M., Sanchez C., Galve-Roperh I. J. Mol. Med. 78:2001;613-625.
39. O'Keefe G.M., Nguyen V.T., Tang L.P., Benveniste E.N. J. Immunol. 166:2001;2260-2269.
40. Nagarajam U.M., Bushey A., Boss J.M. J. Immunol. 169:2002;5078-5088.